Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
Colorcon
Chinese Patent Office
McKesson
Deloitte
Teva
Johnson and Johnson
Moodys
Cantor Fitzgerald

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088571

« Back to Dashboard

NDA 088571 describes LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, which is a drug marketed by Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, and Empi, and is included in thirteen NDAs. It is available from six suppliers. Additional details are available on the LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE profile page.

The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 088571
Tradename:LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Applicant:Hospira
Ingredient:epinephrine; lidocaine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 088571
Suppliers and Packaging for NDA: 088571
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 088571 ANDA Hospira, Inc. 0409-1209 0409-1209-05 400 AMPULE in 1 CASE (0409-1209-05) > 5 mL in 1 AMPULE
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 088571 ANDA Hospira, Inc. 0409-1209 0409-1209-65 800 AMPULE in 1 CASE (0409-1209-65) > 5 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.005MG/ML;1.5%
Approval Date:Sep 13, 1985TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Colorcon
McKesson
Farmers Insurance
Fuji
Baxter
AstraZeneca
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot